BACKGROUND: Little is known about whether @entity955 is a presentation of @entity301 . There is a paucity of knowledge about their causal relationship and also the impact of different antithrombotic strategies on the subsequent presentation of symptomatic @entity301 . METHODS AND RESULTS: We studied 7,526 Chinese @entity1 diagnosed with non-valvular @entity955 and no documented history of @entity453 . The primary endpoint was the new occurrence of @entity453 or @entity1187 . After a mean follow-up of 3.2  3.5 years (24,071 @entity1 -years), a primary endpoint occurred in 987 @entity1 (13.1%). The overall annual incidence of @entity453 was 4.10%/year. No significant differences in age, sex, and mean CHA2DS2-VASc score were observed between @entity1 with and without the primary endpoint. When stratified according to the antithrombotic strategies applied for @entity64 prevention, the annual incidence of @entity453 was 5.49%/year, 4.45%/year and 2.16%/year respectively in those prescribed no antithrombotic therapy, @entity117 , and @entity1229 . Similar trends were observed in @entity1 with @entity1187 . @entity6 , smoking history and @entity177 requiring dialysis were predictors for primary endpoint in all antithrombotic therapies. CONCLUSION: In @entity1 with non-valvular @entity955 , there is a modest association with @entity453 . @entity1 prescribed @entity1229 had the lowest risk of new onset @entity453 .

Impact of Antithrombotic Therapy in @entity955 on the Presentation of XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity1187 :: ('MESH:D054058', 'Disease') :: ['acute coronary syndrome', 'acute coronary syndromes'] @entity64 :: ('MESH:D020521', 'Disease') :: ['stroke'] @entity6 :: ('MESH:D003920', 'Disease') :: ['Diabetes mellitus'] @entity301 :: ('MESH:D003327', 'Disease') :: ['coronary disease'] @entity117 :: ('MESH:D001241', 'Chemical') :: ['aspirin'] @entity177 :: ('MESH:D051437', 'Disease') :: ['renal failure'] @entity955 :: ('MESH:D001281', 'Disease') :: ['atrial fibrillation'] @entity453 :: ('MESH:D003324', 'Disease') :: ['coronary artery disease-either stable coronary artery disease', 'coronary artery disease'] @entity1229 :: ('MESH:D014859', 'Chemical') :: ['warfarin']
@entity453 :: (MESH:D003324,Disease) :: ['Coronary Artery Disease']
